Forensic Analysis · General / Diversified · as of Jun 27, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
A forensic read on CHARLES RIVER LABORATORIES INTERNATIONAL, INC. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Grey Zone
Financial health
1.8
Altman Z-score
Clean
Earnings quality
2
Forensic signals
-5.7%
ROE
$10.4B
Market cap
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 1.8, placing it in the Grey zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
0%Return on invested capital.Return on invested capital is 0% and slipping from 8% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
$380MGoodwill impairments.Took $380M of goodwill writedowns across 2 year(s) (FY2024 ($215M), FY2025 ($165M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Net Margin-3.6%
Debt / Equity0.68x
Free Cash Flow$518.5M
Latest Revenue$4.02B
Return on Equity-4.6%
Revenue Growth YoY-0.9%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about CRL's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown